Home » Tenders » Americas » Brazil » Acquisition of Antineoplastic and Cytostatic Drugs - Part I, to Attend the Uberlândia... Tender

Acquisition of Antineoplastic and Cytostatic Drugs - Part I, to Attend the Uberlândia... Tender

Download Documents

HOSPITAL DAS CLÍNICAS, FEDERAL UNIVERSITY OF UBERLÂNDIA has floated a tender for Acquisition of Antineoplastic and Cytostatic Drugs - Part I, to Attend the Uberlândia Clinical Hospital - Ebserh Branch (hc -ufu/ebserh), According to Conditions, Quantities, Requirements and .... The project location is Brazil and the tender is closing on 28 Sep 2022. The tender notice number is 162/2022, while the TOT Ref Number is 71754521. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Brazil

Summary : Acquisition of Antineoplastic and Cytostatic Drugs - Part I, to Attend the Uberlândia Clinical Hospital - Ebserh Branch (hc -ufu/ebserh), According to Conditions, Quantities, Requirements and ...

Deadline : 28 Sep 2022

Other Information

Notice Type : Tender

TOT Ref.No.: 71754521

Document Ref. No. : 162/2022

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : HOSPITAL DAS CLÍNICAS, FEDERAL UNIVERSITY OF UBERLÂNDIA
Avenida Pará, 1720 - Umuarama - - Uberlândia (MG)
Brazil

Tender Details

Object: Electronic Auction - Acquisition of antineoplastic and cytostatic drugs - Part I, to attend the Uberlândia Clinical Hospital - EBSERH branch (HC -UFU/EBSERH), according to conditions, quantities, requirements and estimates, established in the instrument and its Attachments.

UASG Code: 156654

Notice from: 14/09/2022 from 08:00 to 12:00 and from 13:00 to 17:00 hs

Proposal Delivery: From 14/09/2022 to 08:00

Bevacizumab, concentration 25 mg/ml, pharmaceutical form injectable solution

Quantity: 10

Cyclophosphamide, concentration 1 g, pharmaceutical form liophile powder for injectable

Quantity: 2300

Cyclophosphamide, composition 50 mg

Quantity: 11000

Dacarbazine, concentration 600 mg, pharmaceutical form lipyl powder for injectable

Quantity: 260

Daunorrubicin, dosage 20 mg, injectable presentation

Quantity: 1500

Fludarabine phosphate, dosage 50 mg, type injectable use

Quantity: 350

Fluoruracila, dosage 50 mg/ml, use injectable solution

Quantity: 1200

Calcium Folinet, dosage 15 mg

Quantity: 2500

Gosserrelin acetate, dosage 3.6 mg, indication injectable solution

Quant ...